% Expired Patents = 50.0

Forward Citations = 84

Loading Chart...

2 inventors (with patents filed for the assignee):

Antonio Lanzavecchia (4 out of 65 patents)

Annalisa Macagno (2 out of 38 patents)

4 patents: Sort by Forward Citations

1. 8871207 - Neutralizing anti-influenza A virus antibodies and uses thereof (2014-10-28),

2. 8071371 - Monoclonal antibody production by EBV transformation of B cells (2011-12-06),

3. 7955599 - Human cytomegalovirus neutralizing antibodies and use thereof (2011-06-07),

4. 7947274 - Human cytomegalovirus neutralising antibodies and use thereof (2011-05-24),

Humabs, LLC is a leading biotechnology company specializing in the discovery and development of human monoclonal antibodies for therapeutic use. With a focus on infectious diseases and oncology, Humabs is dedicated to creating innovative solutions that improve patient outcomes. Through cutting-edge research and a commitment to excellence, Humabs is at the forefront of the biotech industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

4 Patents

#895 in San Francisco, CA

#14,019 in California

#60,511 in US

San Francisco, CA, United States of America

Humabs, LLC

Forward Citations = 84

2 inventors:

Antonio Lanzavecchia (4 out of 65 patents)

Annalisa Macagno (2 out of 38 patents)

Please report any incorrect information to [email protected]